Skip to main content

Driven by science, inspired by patients

Science and innovation are the lifeblood of our company. From drug discovery to clinical trials to regulatory approval, we’re pursuing new ways to address patients’ most serious health issues.

Our approach to R&D

At AbbVie, R&D centers around the patient, from understanding disease biology to treatment delivery, clinical trials, and beyond. We combine our experience pioneering scientific breakthroughs, the best ideas in science, and advanced technologies to develop the next generation of medicines.

Since our launch in 2013, we have invested ~$50 billion in R&D, enabling us to discover and deliver innovative medicines and products that solve serious health issues and enhance people’s lives today and address the medical challenges of tomorrow.

We focus our R&D efforts on a core set of therapeutic areas — where we have proven expertise, and see greater potential to improve how diseases are managed. These include oncology, immunology, neuroscience, eye care, virology, and our Allergan Aesthetics portfolio.
 

Explore our pipeline

Powering the future of medicine

We’re working faster and smarter in order to progress our pipeline and deliver more personalized solutions to patients. That means expanding our capabilities across R&D to improve insights and decision making that could lead to better treatments.

Data convergence

We’re investing in big data technology to analyze the growing volume and variety of data available to spark new insights into health and disease. Through data convergence, we're integrating and connecting data, resources and expertise across R&D to accelerate the discovery and development of new therapies for patients.
 

Insights in minutes, not months

See how data convergence is turning the theoretical into the possible.

Learn more.

Precision medicine

Precision medicine already plays an important role in our work, but we envision a future where it will be part of every R&D program. Our researchers are using sophisticated machine learning and artificial intelligence to illuminate predictive relationships from highly complex and multi-modal data, including clinical, molecular, and digital data. These analytical tools are giving teams a look at diseases at a digital pathology level. 
 

The right medicine at the right time

See how we're taking precision medicine beyond oncology.

Learn more.

Genetics and genomics

We believe that we can accelerate drug discovery and development by using human genetic data to select the best targets and indications. Since 2016, we have invested more than $100 million in talent, technology, and human data bringing together functional genomics, human disease genetics, genomic medicine, genome biology, genomic technologies, and computational biology all under one roof. With our comprehensive genomics capability, our functional teams are able to support all therapeutic areas across R&D.

Take a tour inside AbbVie’s Genomic Research Center:

genomics lab

People willing to take chances

Sound like you? We combine the best talent, diverse thinking, and state-of-the-art resources to push the envelope. Because that’s what it takes to discover and deliver new medicines that can improve lives.

Leading the journey from idea to medicine

Our scientific leaders bring diverse experiences, a passion for science, and a bold vision to create transformational medicines for patients.

Research publications

Our science is regularly published in top peer-reviewed journals. By sharing ideas with the scientific community, we can advance new thinking that can ultimately benefit society.

Our products

Search our global list of products or filter by therapeutic area.

Explore

Clinical trials

Read about our approach to clinical trials and search for current trials.

Explore

Our science stories

Learn more about our innovative science and the people making it happen.

Explore